Evofem Biosciences Inc (EVFM) PT Raised to $25 at Oppenheimer Following FDA Approval of Phexxi
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell raised the price target on Evofem Biosciences Inc (NASDAQ: EVFM) to $25.00 (from $23.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
